Joao Pereira, PhD
Cards
About
Titles
Associate Professor Tenure
Biography
Dr. João P. Pereira is an associate professor of Immunobiology, member of the Yale Cancer Center and of the Yale Stem Cell Center. He studied Microbiology at Universidade Católica Portuguesa (BSc, 1996), Biotechnology at DeMontfort University (MSc, 1997), and did PhD studies (Universidade do Porto, 2004) in Immunology at the Gulbenkian Institute (Oeiras) and the Pasteur Institute (Paris) mentored by Paulo Vieira. In 2005 Dr. Pereira joined the laboratory of Dr. Jason Cyster (UCSF) as a Howard Hughes Medical Institute Postdoctoral fellow. In the Cyster lab he studied mechanisms of B lymphocyte migration during development in primary lymphoid organs and during activation in secondary lymphoid organs. Dr. Pereira joined the department of Immunobiology at Yale University in 2010.
Appointments
Immunobiology
Associate Professor TenurePrimary
Other Departments & Organizations
- Cancer Immunology
- Immunobiology
- Immunology
- Molecular Cell Biology, Genetics and Development
- Rheumatic Diseases Research Core
- Rheumatology, Allergy, & Immunology
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Stem Cell Center
- Yale Ventures
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
Education & Training
- PhD
- University of Porto (2004)
- MS
- DeMontfort University (1997)
- BSc
- Universidade Católica Portuguesa, Microbiology
Research
Overview
Active areas of research
1- Bone marrow Stem Cell niches
All blood cells develop from hematopoietic stem cells (HSC) through complex developmental transitions that require cell-lineage instructive transcription factors and cell-extrinsic lineage-instructive cytokines. Stem cell niches are key organizers of HSC maintenance and differentiation due to their capacity to produce cytokines (e.g. Stem Cell Factor, IL-7, IL-15, etc.) and chemokines (e.g. CXCL12). Stem cell niches are formed predominantly by a relatively rare population of mesenchymal stem/progenitor cells (MSPCs) that expresses Leptin receptor and PDGFRs. Importantly, MSPCs either reduce or loose the ability to express niche cytokines upon differentiation into mesenchymal-lineage cells such as adipocytes, osteoblasts, chondrocytes. These observations suggest that cytokine production by MSPCs is regulated by short and/or long-range signals, but these mechanisms are largely unknown. Also poorly understood is the physiological role of MSPCs in the long-term maintenance of antibody-secreting plasma cells.
2- Where and how B cell development occurs in vivo.
B cell precursors switch from non-motile and highly adherent states (proB cell stage) to highly motile and less adherent states (preB cell stage). As a consequence, the time these two distinct B cell subsets spend in contact with IL-7 producing MSPCs is remarkably different and highly regulated. This type of change in dynamic behavior suggests that cross-talk between proB, preB, and MSPCs is important for the quality and possibly quantity of B cells being produced. This is a highly exciting area of research that is likely to have a major impact in our understanding of how pre-leukemic and leukemic B cell progenitors change the bone marrow microenvironment.
3- Chemoattractants, receptors, and B cell homeostasis.
Immune cells are highly organized in primary and secondary lymphoid organs. B cells and T cells occupy distinct areas of the spleen and lymph nodes due to the differential expression of chemoattractant receptors. Chemoattractants act as ZIP codes for immune cells to know where they should be located. However, chemoattractant receptor signaling does more to cells than simply inform them of where they are or where they should go. By taking advantage of one of nature’s tools, Pertussis toxin, we are currently investigating the physiological impact of blocked chemoattractant receptor signaling in the development and maintenance of B cells.